Liquidia Corporation (LQDA)
NASDAQ·Healthcare·Biotechnology
$71.08
-0.76%
Mkt Cap $6.37B
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$50.67
Range $47.00 – $55.00
Implied Upside
-28.7%
Consensus $50.67 vs current $71.08
NASDAQ·Healthcare·Biotechnology
$71.08
-0.76%
Mkt Cap $6.37B
No recent rating data.
Price Target (15 analysts)
$50.67
Range $47.00 – $55.00
-28.7%
Consensus $50.67 vs current $71.08